Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to th...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!